Detalhe da pesquisa
1.
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αß+ T cells targeting multiple myeloma.
Blood
; 143(10): 895-911, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890146
2.
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma.
Blood
; 143(11): 996-1005, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992230
3.
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.
Blood
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551812
4.
Single-cell profiling in multiple myeloma: insights, problems, and promises.
Blood
; 142(4): 313-324, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196627
5.
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma.
Blood
; 141(21): 2599-2614, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630605
6.
High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.
Blood
; 141(14): 1724-1736, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603186
7.
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.
Blood
; 141(23): 2841-2852, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877894
8.
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.
Blood
; 141(4): 391-405, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126301
9.
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
N Engl J Med
; 384(8): 705-716, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626253
10.
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.
Gastroenterology
; 165(2): 357-373, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178737
11.
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification.
Haematologica
; 109(1): 231-244, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439377
12.
Risk factors in multiple myeloma: is it time for a revision?
Blood
; 137(1): 16-19, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024991
13.
IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.
Blood
; 138(20): 1980-1985, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792571
14.
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance.
Blood
; 138(20): 1966-1979, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132782
15.
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
Blood
; 137(14): 1905-1919, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751108
16.
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System.
Pharmacoepidemiol Drug Saf
; 32(5): 558-566, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458420
17.
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma.
Cancer
; 128(10): 1996-2004, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167125
18.
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Lancet
; 398(10297): 314-324, 2021 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175021
19.
CD44 v5 domain inhibition represses the polarization of Th2 cells by interfering with the IL-4/IL-4R signaling pathway.
Immunol Cell Biol
; 100(1): 21-32, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34219288
20.
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Blood
; 136(26): 3033-3040, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367546